journal article·2024-09Open access

Programmable Bacteria with Dynamic Virulence Modulation System for Precision Antitumor Immunity

Leyang Wu, Lin Li, Liyuan Qiao, Chenyang Li, Shuhui Zhang, Xingpeng Yin, Zengzheng Du, Ying Sun, Jiahui Qiu, Xiaoyao Chang, Bohao Wang, Zichun Hua

Advanced Science· Volume 11· Issue 36

Abstract

Abstract Engineered bacteria‐mediated antitumor approaches have been proposed as promising immunotherapies for cancer. However, the off‐target bacterial toxicity narrows the therapeutic window. Living microbes will benefit from their controllable immunogenicity within tumors for safer antitumor applications. In this study, a genetically encoded microbial activation strategy is reported that uses tunable and dynamic expression of surface extracellular polysaccharides to improve bacterial biocompatibility while retaining therapeutic efficacy. Based on screening of genes associated with Salmonella survival in macrophages, a novel attenuated Salmonella chassis strain AIS ( htrA gene‐deficient) highly enriched in tumors after administration and rapidly cleared from normal organs are reported. Subsequently, an engineered bacterial strain, AISI‐H, is constructed based on the AIS strain and an optimized quorum‐sensing regulatory system. The AISI‐H strain can achieve recovery of dynamic tumor‐specific bacterial virulence through a novel HTRA‐RCSA axis‐based and quorum‐sensing synthetic gene circuit‐mediated increase in extracellular polysaccharide content. These strains act “off” in normal organs to avoid unwanted immune activation and “on” in tumors for precise tumor suppression in mice. The AISI‐H strain shows significant tumor inhibition and potent activation of anticancer immunity in a melanoma mouse model. The AISI‐H strain exhibits excellent biocompatibility. This bacterial regulation strategy expands the applications of microbe‐based antitumor therapeutics.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Cancer Research and Treatments · Nanoplatforms for cancer theranostics · Virus-based gene therapy research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology of Nanjing Drum Tower Hospital and The State Key Laboratory of Pharmaceutical Biotechnology School of Life Sciences and The Affiliated Hospital of Nanjing University Medical School Nanjing University Nanjing Jiangsu 21008 P. R. China

Nanjing Generecom Biotechnology Co., Ltd. Nanjing Jiangsu 210023 P. R. China

Changzhou High‐Tech Research Institute of Nanjing University and Jiangsu TargetPharma Laboratories, Inc. Changzhou Jiangsu 213164 P. R. China

Faculty of Pharmaceutical Sciences Xinxiang Medical University Xinxiang Henan 453002 P. R. China

Funding

Natural Science Foundation of Jiangsu Province · China Postdoctoral Science Foundation

References (58)

Show source-provided references
1. 10.1038/520510.1038/5205 ↗
2. 10.1016/j.xcrm.2023.10107010.1016/j.xcrm.2023.101070 ↗
3. 10.1038/s41568-018-0070-z10.1038/s41568-018-0070-z ↗
4. 10.1021/jacs.2c0728710.1021/jacs.2c07287 ↗
5. 10.1038/s41392-023-01703-110.1038/s41392-023-01703-1 ↗
6. 10.1016/j.addr.2022.11436310.1016/j.addr.2022.114363 ↗
7. 10.1126/science.add703410.1126/science.add7034 ↗
8. 10.1126/science.add966710.1126/science.add9667 ↗
9. 10.1126/sciadv.adc943610.1126/sciadv.adc9436 ↗
10. 10.1200/JCO.2002.20.1.14210.1200/JCO.2002.20.1.142 ↗
11. 10.1038/s41591-019-0626-910.1038/s41591-019-0626-9 ↗
12. 10.1016/j.apsb.2022.05.00610.1016/j.apsb.2022.05.006 ↗
13. 10.1038/ncomms767310.1038/ncomms7673 ↗
14. 10.1086/31549710.1086/315497 ↗
15. 10.2174/156652402336249210.2174/1566524023362492 ↗
16. 10.1126/science.aba802610.1126/science.aba8026 ↗
17. 10.1016/j.chom.2022.01.00810.1016/j.chom.2022.01.008 ↗
18. 10.1128/JB.00898-0710.1128/JB.00898-07 ↗
19. 10.1038/s41587-022-01244-y10.1038/s41587-022-01244-y ↗
20. 10.1016/j.apsb.2021.04.01910.1016/j.apsb.2021.04.019 ↗
21. 10.1073/pnas.040842210210.1073/pnas.0408422102 ↗
22. 10.7150/thno.8734010.7150/thno.87340 ↗
23. 10.1155/2016/567870210.1155/2016/5678702 ↗
24. 10.1038/sj.cgt.770063410.1038/sj.cgt.7700634 ↗
25. 10.1038/nature1893010.1038/nature18930 ↗
26. 10.1038/s41467-020-15056-810.1038/s41467-020-15056-8 ↗
27. 10.1073/pnas.141455811210.1073/pnas.1414558112 ↗
28. 10.1038/s41551-021-00772-310.1038/s41551-021-00772-3 ↗
29. 10.1126/science.aat714810.1126/science.aat7148 ↗
30. 10.1038/ni.312310.1038/ni.3123 ↗
31. 10.1038/nrmicro.2017.9910.1038/nrmicro.2017.99 ↗
32. 10.7554/eLife.7093110.7554/eLife.70931 ↗
33. 10.1146/annurev-micro-090817-06264010.1146/annurev-micro-090817-062640 ↗
34. 10.1128/jb.173.5.1738-1747.199110.1128/jb.173.5.1738-1747.1991 ↗
35. Wang M. · Microorganisms · 2020 · 8
36. 10.1093/toxsci/kfq13410.1093/toxsci/kfq134 ↗
37. Wu L. · J. Appl. Microbiol. · 2022
38. 10.4049/jimmunol.090347910.4049/jimmunol.0903479 ↗
39. 10.1002/pro.213210.1002/pro.2132 ↗
40. 10.1016/j.carbpol.2016.04.09710.1016/j.carbpol.2016.04.097 ↗
41. 10.1016/j.addr.2023.11489710.1016/j.addr.2023.114897 ↗
42. 10.1021/jacs.3c0268210.1021/jacs.3c02682 ↗
43. 10.18632/oncotarget.1839210.18632/oncotarget.18392 ↗
44. Coley W. B. · Clin. Orthop. Relat. Res. · 1991 · 3 · 262
45. 10.1136/bmj.1.4768.111610.1136/bmj.1.4768.1116 ↗
46. 10.1038/nrm306510.1038/nrm3065 ↗
47. 10.1111/lam.1299910.1111/lam.12999 ↗
48. 10.1186/s43141-019-0005-410.1186/s43141-019-0005-4 ↗
49. 10.1016/j.vaccine.2003.10.05310.1016/j.vaccine.2003.10.053 ↗
50. 10.1016/j.addr.2022.11444310.1016/j.addr.2022.114443 ↗
51. 10.1016/j.nantod.2022.10153710.1016/j.nantod.2022.101537 ↗
52. 10.1046/j.1365-2958.2003.03313.x10.1046/j.1365-2958.2003.03313.x ↗
53. E.Richard O. N.Michael P.Alexander A.Natasha S.Andrew G.Tim Ž.Augustin B.Russ B.Sam Y.Jason R.Olaf B.Sebastian Z.Michal B.Alex P.Anna C.Andrew T.Kathryn J.Rishub C.Ellen K.Pushmeet J.John H.Demis (Preprint) bioRxiv:10.04.463034 v1 submitted: Oct. 2021.
54. 10.1002/pro.394310.1002/pro.3943 ↗
55. J.‐S.Lin E.‐M.Lai inBacterial Protein Secretion Systems(Eds:E. L.Journet E.Cascales) Vol.1615 Springer Humana Press New York2017 pp211–219.
56. 10.1021/acschembio.5b0075310.1021/acschembio.5b00753 ↗
57. 10.1038/s42003-022-03832-910.1038/s42003-022-03832-9 ↗
58. 10.1016/j.apsb.2022.05.00610.1016/j.apsb.2022.05.006 ↗